PHG vs WST
Koninklijke Philips N.V. vs West Pharmaceutical Services — AI-powered side-by-side comparison
PHG
Koninklijke Philips N.V.
61
Buy
VS
WST
West Pharmaceutical Services
74
Buy
| Metric | PHG | WST |
|---|
| AI Score |
61
|
74
|
| Price |
$27.06
|
$351.74
|
| P/E Ratio |
20.13×
|
44.65×
|
| ROE |
8.2%
|
15.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
45.9%
|
36.8%
|
| Debt / Equity |
0.65×
|
0.10×
|
| Dividend Yield |
3.6%
|
0.3%
|
| RSI (14) |
64.1
|
58.0
|
| Beta |
0.916
|
1.138
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for PHG versus WST.
WST leads by 13 points.
WST scores 74/100 (Buy) versus PHG at 61/100 (Buy).
PHG Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Dividend yield of 4.2% pays you to wait — Value
- EPS growing 157.8% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Revenue declining -25.8% YoY -- this is not a growth story right now — Growth
WST Committee View
100% agreement
5 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical